David Einstein News Today

Good morning welcome to squawk alley. Joining me this morning, sarah eisen and mike santoli and the the senates new Health Care Plan in a joint statement, rand paul, ted cruz, mike lee and lee johnson say it doesnt do enough to repeal obamacare. Republicans can only afford two no votes the aarp, American Hospital association and others have also come out against this bill health care stocks, though, surging following the drafts release. Theyre on pace for the best week of the year maybe some pro...

To start 2024 on a well-informed note, read on to learn about 20 trends agencies will want to keep an eye on (and get ahead of) this year.

The power of a newsletter to reach and motivate audiences in the digital age can be potent if brands take the right approach to ideating, creating and distributing one.

Successfully integrating AI into operations and revenue generation can result in significant market advantages.

ONEgeneration senior center in Reseda expanded its services to the Wilkinson Senior Center in Northridge this week to help more seniors keep their vim and vigor,

Over the last decade, golf course architect Gil Hanse has become one of the most respected and most sought-after architects in the country. This week, the best golfers in the world will tee it up at The Country Club in Brookline, M

Trial evaluates onvansertib in combination with abiraterone and prednisone in metastatic castration-resistant prostate cancer (mCRPC) patients showing initial...

/PRNewswire/ -- The Prostate Cancer Foundation (PCF) today announced the Class of 2021 Young Investigator Award recipients totaling nearly $6.5 million in...

Share this article SAN DIEGO, April 10, 2021 /PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company developing onvansertib to treat cancers with the greatest medical need for new treatment options, including KRAS-mutated colorectal cancer, pancreatic cancer and castrate-resistant prostate cancer, in collaboration with scientists in the Center for Precision Cancer Medicine at the Massachusetts Institute of Technology (MIT), today announced that new gene s...

Cardiff Oncology Announces Upcoming Presentations at the AACR Annual Meeting 2021 News provided by Share this article SAN DIEGO, March 10, 2021 /PRNewswire/ -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company developing drugs to treat cancers with the greatest medical need for new treatment options, including KRAS-mutated colorectal cancer, pancreatic cancer, castrate-resistant prostate cancer and leukemias, today announced the publication of two abstracts that wi...